title: [Changes in the sensitivity of clinical strains of Staphylococcus aureus caused by cefamandole, cefoperazone and 6-alpha-bromopenicillanic acid sulfone in vitro].
authors.forename: D
authors.initials: D
authors.lastname: Jastalska
authors.forename: W
authors.initials: W
authors.lastname: Lupicki
authors.forename: M
authors.initials: M
authors.lastname: Zapaśnik
authors.forename: G
authors.initials: G
authors.lastname: Pajchel
authors.forename: W
authors.initials: W
authors.lastname: Chojnowski
mesh_terms: D002435:Cefamandole / Q000494:pharmacology*; D002438:Cefoperazone / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D066298:In Vitro Techniques; D010397:Penicillanic Acid / Q000494:pharmacology* / Q000031:analogs & derivatives; D013211:Staphylococcus aureus / Q000187:drug effects*
chemical_list: D002435:Cefamandole; C018008:brobactam; D002438:Cefoperazone; D010397:Penicillanic Acid
vernacular_title: Zmiany wrazliwości klinicznych szczepów Staphylococcus aureus wywołane cefamandolem, cefoperazonem i sulfonem kwasu 6-alfa-bromopenicylanowego in vitro.